Unexplainable

The accidental rise of Botox

March 18, 2026

Key Takeaways Copied to clipboard!

  • Botox, derived from the deadly botulinum toxin (first linked to sausage poisoning, or botulism, in the 1800s by Justinus Kerner), has evolved from treating ophthalmological conditions like strabismus to becoming a widely used medical and cosmetic treatment. 
  • The cosmetic use of Botox originated serendipitously when Jean Carruthers observed a patient enjoying the 'beautiful, untroubled expression' caused by injections intended to treat blepharospasm, leading to its application for frown lines. 
  • Botulinum toxin acts by stopping nerves from secreting chemicals, which not only paralyzes muscles (used for conditions like spasticity and excessive sweating) but is also being explored for pain relief and potentially as an antidepressant via the facial feedback hypothesis. 

Segments

Botox Origin and Early History
Copied to clipboard!
(00:00:56)
  • Key Takeaway: Botulism, a paralytic disease linked to contaminated sausages, was first scientifically investigated by Justinus Kerner in the 1820s, who recognized its potential for treating overactive muscle conditions.
  • Summary: The host recounts receiving Botox injections in her throat to treat a condition preventing her from burping, highlighting the drug’s derivation from a poison. Justinus Kerner investigated the paralytic disease known as botulism, caused by contaminated sausages, and even tested a small amount on himself to study its effects. Kerner theorized that the toxin, in small doses, could be useful for treating muscle overactivity, echoing Paracelsus’s principle that only the dose determines if something is poisonous.
Toxin Isolation and Eye Treatments
Copied to clipboard!
(00:07:23)
  • Key Takeaway: Botulinum toxin was isolated during WWII research aimed at preventing its use as a biological weapon, leading Alan Scott to pioneer its use for treating strabismus and blepharospasm.
  • Summary: Researchers studied the toxin during WWII, and Ed Shance isolated it, supplying it for research afterward. Ophthalmologist Alan Scott used the toxin to successfully treat strabismus (crossed eyes) by weakening the pulling muscle. Jean Carruthers learned this technique from Scott and began treating patients with blepharospasm, a condition causing involuntary eye closure.
Cosmetic Botox Discovery
Copied to clipboard!
(00:09:23)
  • Key Takeaway: The cosmetic application of Botox was discovered when a blepharospasm patient requested treatment between her eyebrows because it resulted in a ‘beautiful, untroubled expression.’
  • Summary: A patient being treated for eye spasms noted that injections between her eyebrows, though not spasming there, resulted in a pleasing cosmetic effect. Jean Carruthers shared this idea with her dermatologist husband, Alistair, leading to a study on treating frown lines. Initial public resistance to injecting a poison for cosmetic reasons was overcome by showing positive results, with Carruthers herself becoming an early subject.
Expansion of Medical Uses
Copied to clipboard!
(00:13:35)
  • Key Takeaway: Botox expanded beyond ophthalmology and dermatology to treat various movement disorders, hyperhydrosis, and even overactive bladder by stopping the secretion of key neurotransmitters.
  • Summary: David Simpson, a neurologist, began using the toxin in the early 90s to treat severe spasticity in a patient’s arm following a traumatic brain injury. The drug’s mechanism involves stopping nerves from secreting chemicals, including those that signal muscle movement and pain. This fundamental action allows it to treat numerous conditions, leading to FDA approvals for nine medical problems and many off-label uses.
Migraine and Pain Relief
Copied to clipboard!
(00:19:04)
  • Key Takeaway: Migraine treatment with Botox emerged after patients receiving cosmetic injections reported reduced headaches, suggesting the toxin relieves pain by blocking neurotransmitter release.
  • Summary: Cosmetic users reported fewer migraines, prompting studies that led to FDA approval for migraine treatment. The adage is that if a condition moves, Botox can stop it, but this is now extended to pain relief. The toxin blocks neurotransmitters responsible for muscle movement and also those involved in pain signaling.
Depression and Future Indications
Copied to clipboard!
(00:22:30)
  • Key Takeaway: Research suggests Botox may act as an antidepressant by preventing frowning, supporting the facial feedback hypothesis, though its mechanism for systemic mood alteration remains unclear.
  • Summary: Axel Wollmer, a psychiatrist, investigated Botox for depression based on the facial feedback hypothesis: freezing ‘grief muscles’ (frown lines) should improve mood. Small studies confirmed this effect, though a large trial is still needed. Furthermore, emerging research suggests Botox might help shrink tumors by blocking nerve signals that aid tumor growth.